These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12241800)

  • 1. Oral contraceptives and cervical cancer.
    Berrington A; Jha P; Peto J; Green J; Hermon C;
    Lancet; 2002 Aug; 360(9330):410. PubMed ID: 12241800
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oral contraceptive and the increased risk of cervical cancer].
    Heikinheimo O; Leminen A
    Duodecim; 2003; 119(24):2405-6. PubMed ID: 14870500
    [No Abstract]   [Full Text] [Related]  

  • 3. WHO links long term pill use to cervical cancer.
    Dyer O
    BMJ; 2002 Apr; 324(7341):808. PubMed ID: 11934771
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral contraceptives and cervical cancer.
    Brabin L; Barr F
    Lancet; 2002 Aug; 360(9330):409-10. PubMed ID: 12241799
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral contraceptives, parity, and cervical cancer.
    Skegg DC
    Lancet; 2002 Mar; 359(9312):1080-1. PubMed ID: 11943251
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study.
    Moreno V; Bosch FX; Muñoz N; Meijer CJ; Shah KV; Walboomers JM; Herrero R; Franceschi S;
    Lancet; 2002 Mar; 359(9312):1085-92. PubMed ID: 11943255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas.
    Lacey JV; Brinton LA; Abbas FM; Barnes WA; Gravitt PE; Greenberg MD; Greene SM; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Silverberg SG; Hildesheim A
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1079-85. PubMed ID: 10613340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptives, human papillomavirus and cervical cancer.
    La Vecchia C; Boccia S
    Eur J Cancer Prev; 2014 Mar; 23(2):110-2. PubMed ID: 24469243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of oral contraceptives as risk factors for papillomavirus infection and cervical intraepithelial neoplasia].
    Suárez Rincón M; Suárez Rincón CA
    Ginecol Obstet Mex; 2005 Jun; 73(6):340-1. PubMed ID: 16309042
    [No Abstract]   [Full Text] [Related]  

  • 10. [Risk factors and prevention of uterine cervical cancer].
    Kawagoe T; Toki N; Matsuura Y; Kashimura M
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():233-6. PubMed ID: 15535242
    [No Abstract]   [Full Text] [Related]  

  • 11. Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking.
    Castellsagué X; Muñoz N
    J Natl Cancer Inst Monogr; 2003; (31):20-8. PubMed ID: 12807941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus antibody responses among patients with incident cervical carcinoma.
    Wang Z; Konya J; Avall-Lundkvist E; Sapp M; Dillner J; Dillner L
    J Med Virol; 1997 Aug; 52(4):436-40. PubMed ID: 9260694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus, cervical cancer prevention, and more.
    Lowy D
    Vaccine; 2008 Aug; 26 Suppl 10():iii-iv. PubMed ID: 18847562
    [No Abstract]   [Full Text] [Related]  

  • 14. [Papillomavirus infections and cervical tumorigenesis].
    Kiyono T
    Gan To Kagaku Ryoho; 2010 Feb; 37(2):227-31. PubMed ID: 20235389
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral contraceptives and cervical cancer.
    Vessey MP; Lawless M; McPherson K; Yeates D
    Lancet; 1983 Dec; 2(8363):1358-9. PubMed ID: 6139685
    [No Abstract]   [Full Text] [Related]  

  • 16. HPV types and cofactors causing cervical cancer in Peru.
    Santos C; Muñoz N; Klug S; Almonte M; Guerrero I; Alvarez M; Velarde C; Galdos O; Castillo M; Walboomers J; Meijer C; Caceres E
    Br J Cancer; 2001 Sep; 85(7):966-71. PubMed ID: 11592767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus.
    Shields TS; Brinton LA; Burk RD; Wang SS; Weinstein SJ; Ziegler RG; Studentsov YY; McAdams M; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1574-82. PubMed ID: 15466972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomaviruses and cervical cancer in Bangkok. I. Risk factors for invasive cervical carcinomas with human papillomavirus types 16 and 18 DNA.
    Thomas DB; Ray RM; Koetsawang A; Kiviat N; Kuypers J; Qin Q; Ashley RL; Koetsawang S
    Am J Epidemiol; 2001 Apr; 153(8):723-31. PubMed ID: 11296143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiologic determinants of seroreactivity to human papillomavirus (HPV) type 16 virus-like particles in cervical HPV-16 DNA-positive and-negative women.
    Wideroff L; Schiffman MH; Hoover R; Tarone RE; Nonnenmacher B; Hubbert N; Kirnbauer R; Greer CE; Lorincz AT; Manos MM; Glass AG; Scott DR; Sherman ME; Buckland J; Lowy D; Schiller J
    J Infect Dis; 1996 Nov; 174(5):937-43. PubMed ID: 8896493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pill and cervical cancer: the causal association.
    Leppäluoto PA
    Acta Cytol; 2006; 50(6):704-6. PubMed ID: 17152288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.